Trellis Bioscience

The next 21st century breakthrough in monoclonal antibody technology is currently housed at Trellis Bioscience. This South San Francisco company has developed a breakthrough technology platform for cellular informatics. Trellis uses nanotechnology, software and digital microscopy to better locate and recover the original rare favorable cells which will be used to make monoclonal antibodies.

Website